T-regulatory lymphocytes and chronic viral hepatitis

Expert Opinion on Biological Therapy

Volumn 7, Issue 11, 2007, Pages 1689-1703

  Rushbrook, Simon M ^a   Hoare, Matthew ^a   Alexander, Graeme J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

FoxP3; Hepatitis B; Hepatitis C; Regulatory T cells; Viral hepatitis

Indexed keywords

HEPATITIS B CORE ANTIBODY;

ADAPTIVE IMMUNITY; CD4 CD8 RATIO; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS HEPATITIS; IMMUNOLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 36048996837     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.7.11.1689     Document Type: Review

References (95)

1. CHAN HL, SUNG JJ: Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. (2006) 26:153-161.
2. KANE M: Global programme for control of hepatitis B infection. Vaccine (1995) (13 Suppl.) 1:S47-S49.
3. LEE WM: Hepatitis B virus infection. N Engl. J. Med. (1997) 337:1733-1745.
4. POYNARD T, YUEN MF, RATZIU V, LAI CL: Viral hepatitis C. Lancet (2003) 362:2095-2100.
5. FARCI P, ALTER HJ, GOVINDARAJAN S et al.: Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 258:135-140.
6. KATZE MG, HE Y, GALE M Jr: Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. (2002) 2:675-687.
7. CARRENO V, PARDO M, LOPEZ-ALCOROCHO JM, RODRIGUEZ-INIGO E, BARTOLOME J, CASTILLO I: Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J. Infect. Dis. (2006) 194:53-60.
8. CARRENO V: Occult hepatitis C virus infection: a new form of hepatitis C. World J. Gastroenterol. (2006) 12:6922-6925.
9. BOWEN DG, WALKER CM: Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature (2005) 436:946-952.
10. LECHNER F, WONG DK, DUNBAR PR et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. (2000) 191:1499-1512.
11. FERRARI C, PENNA A, BERTOLETTI A et al.: Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. (1990) 145:3442-3449.
12. JUNG MC, SPENGLER U, SCHRAUT W et al.: Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. (1991) 13:310-317.
13. PENNA A, DEL PG, CAVALLI A et al.: Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology (1997) 25:1022-1027.
14. MAINI MK, BONIC, OGG GS et al.: Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 117:1386-1396.
15. FERRARI C, BERTOLETTI A, PENNA A et al.: Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. (1991) 88:214-222.
16. PENNA A, CHISARI FV, BERTOLETTI A et al.: Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. (1991) 174:1565-1570.
17. + T cells in vitro. J. Virol. (1996) 70:7540-7548.
18. PENNA A, ARTINI M, CAVALLI A et al.: Long-lasting memory T cell responses following self-limited acute hepatitis B. J. Clin. Invest. (1996) 98:1185-1194.
19. REHERMANN B, LAU D, HOOFNAGLE JH, CHISARI FV: Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. (1996) 97:1655-1665.
20. JUNG MC, SPENGLER U, SCHRAUT W et al.: Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. (1991) 13:310-317.
21. SUGIMOTO K, IKEDA F, STADANLICK J, NUNES FA, ALTER HJ, CHANG KM: Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology (2003) 38:1437-1448.
22. GERLACH JT, DIEPOLDER HM, JUNG MC et al.: Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 117:933-941.
23. CACCIARELLI TV, MARTINEZ OM, GISH RG, VILLANUEVA JC, KRAMS SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon α. Hepatology (1996) 24:6-9.
24. TSAI SL, LIAW YF, CHEN MH, HUANG CY, KUO GC: Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology (1997) 25:449-458.
25. MILICH DR, JONES JE, HUGHES JL, PRICE J, RANEY AK, MCLACHLAN A: Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA (1990) 87:6599-6603.
26. MILICH DR, SCHODEL F, PETERSON DL, JONES JE, HUGHES JL: Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur. J. Immunol. (1995) 25:1663-1672.
27. MILICH DR, SCHODEL F, HUGHES JL, JONES JE, PETERSON DL: The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J. Virol. (1997) 71:2192-2201.
28. MILICH DR, CHEN MK, HUGHES JL, JONES JE: The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. (1998) 160:2013-2021.
29. WANG H, ECKELS DD: Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J. Immunol. (1999) 162:4177-4183.
30. + T cell responses in chronically infected and non-viremic patients. Eur. J. Immunol. (2001) 31:1438-1446.
31. ROSEN HR, HINRICHS DJ, GRETCH DR et al.: Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology (1999) 117:926-932.
32. ARTINI M, NISINI R, MISSALE G et al.: Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. Viral Immunol. (1995) 8:63-73.
33. FIORE G, ANGARANO I, CACCETTA L et al.: In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur. J. Gastroenterol. Hepatol. (1997) 9:491-496.
34. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. (1993) 178:17-25.
35. BARNES E, HARCOURT G, BROWN D, LUCAS M, PHILLIPS R, DUSHEIKO G, KLENERMAN P: The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology (2002) 36:743-754.
36. LOK AS: Chronic hepatitis B. N Engl. J. Med. (2002) 346:1682-1683.
37. BONI C, BERTOLETTI A, PENNA A et al.: Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. (1998) 102:968-975.
38. MARINOS G, NAOUMOV NV, WILLIAMS R: Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology (1996) 24:991-995.
39. LECHNER F, WONG DK, DUNBAR PR et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. (2000) 191:1499-1512.
40. LECHNER F, WONG DK, DUNBAR PR et al.: Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. (2000) 191:1499-1512.
41. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. (2004) 78:5707-5719.
42. REIGNAT S, WEBSTER GJ, BROWN D et al.: Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. (2002) 195:1089-1101.
43. BONI C, PENNA A, BERTOLETTI A et al.: Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J. Hepatol. (2003) 39:595-605.
44. MAINI MK, BONI C, OGG GS et al.: Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 117:1386-1396.
45. WEBSTER GJ, REIGNAT S, MAINI MK et al.: Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 32:1117-1124.
46. MAINI MK, BONI C, LEE CK et al.: The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. (2000) 191:1269-1280.
47. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. (2002) 8:379-385.
48. + T cells. J. Immunol. (2004) 172:1744-1753.
49. BARBER DL, WHERRY EJ, MASOPUST D et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439:682-687.
50. DAY CL, KAUFMANN DE, KIEPIELA P et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 443:350-354.
51. PENNAA, PILLIM, ZERBINIA et al.: Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology (2007) 45:588-601.
52. BARBER DL, WHERRY EJ, MASOPUST D et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439:682-687.
53. DAY CL, KAUFMANN DE, KIEPIELA P et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 443:350-354.
54. URBANI S, AMADEI B, TOLA D et al.: PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. (2006) 80:11398-11403.
55. + cells in HCV-positive livers.
56. NISHIZUKA Y, SAKAKURA T: Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science (1969) 166:753-755.
57. KOJIMA A, TANAKA-KOJIMA Y, SAKAKURA T, NISHIZUKA Y: Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab. Invest. (1976) 34:550-557.
58. KOJIMA A, TAGUCHI O, NISHIZUKA Y: Experimental production of possible autoimmune gastritis followed by macrocytic anemia in athymic nude mice. Lab. Invest. (1980) 42:387-395.
59. SAKAGUCHI S, TAKAHASHI T, NISHIZUKA Y: Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. (1982) 156:1577-1586.
60. SAKAGUCHI S, TAKAHASHI T, NISHIZUKA Y: Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. (1982) 156:1565-1576.
61. + T cells. Immunity (1994) 1:553-562.
62. + T cells. J. Exp. Med. (1993) 178:237-244.
63. + T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. (1990) 172:1701-1708.
64. SAKAGUCHI S, SAKAGUCHI N, ASANO M, ITOH M, TODA M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. (1995) 155:1151-1164.
65. ASANO M, TODA M, SAKAGUCHI N, SAKAGUCHI S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. (1996) 184:387-396.
66. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. (1998) 160:1212-1218.
67. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. (1998) 188:287-296.
68. NG WF, DUGGAN PJ, PONCHEL F et al.: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood (2001) 98:2736-2744.
69. DIECKMANN D, PLOTTNER H, BERCHTOLD S, BERGER T, SCHULER G: Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. (2001) 193:1303-1310.
70. JONULEIT H, SCHMITT E, STASSEN M, TUETTENBERG A, KNOP J, ENK AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. (2001) 193:1285-1294.
71. TAAMS LS, SMITH J, RUSTIN MH, SALMON M, POULTER LW, AKBAR AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. (2001) 31:1122-1131.
72. LEVINGS MK, SANGREGORIO R, RONCAROLO MG: Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. (2001) 193:1295-1302.
73. +. Scand. J. Immunol. (2002) 55:606-611.
74. ANNUNZIATO F, COSMI L, LIOTTA F et al.: Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. (2002) 196:379-387.
75. STEPHENS LA, MOTTET C, MASON D, POWRIE F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. (2001) 31:1247-1254.
76. +CD25 high regulatory cells in human peripheral blood. J. Immunol. (2001) 167:1245-1253.
77. + regulatory T cells. Eur. J. Immunol. (2002) 32:1621-1630.
78. TAKAHASHI T, TAGAMI T, YAMAZAKI S et al.: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. (2000) 192:303-310.
79. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737-742.
80. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. (2000) 30:1538-1543.
81. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. (2004) 172:4676-4680.
82. + regulatory cells that control intestinal inflammation. J. Exp. Med. (2000) 192:295-302.
83. + regulatory T cells. Eur. J. Immunol. (2002) 32:2888-2896.
84. + T lymphocytes. J. Immunol. (2005) 174:155-163.
85. + T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J. Allergy Clin. Immunol. (2003) 111:862-868.
86. + regulatory thymocytes because of their responsiveness to different cytokines. Blood (2004) 103:3117-3121.
87. DIECKMANN D, BRUETT CH, PLOETTNER H, LUTZ MB, SCHULER G: Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. (2002) 196:247-253.
88. JONULEIT H, SCHMITT E, KAKIRMAN H, STASSEN M, KNOP J, ENK AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. (2002) 196:255-260.
89. + regulatory T cells. Nat. Immunol. (2003) 4:330-336.
90. HORI S, NOMURA T, SAKAGUCHI S: Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299:1057-1061.
91. GAMBINERI E, TORGERSON TR, OCHS HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. (2003) 15:430-435.
92. BETTELLI E, DASTRANGE M, OUKKA M: Foxp3 interacts with nuclear factor of activated T cells and NF-{κ}B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA (2005) 102:5138-5143.
93. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. (2003) 198:1875-1886.
94. + regulatory T cells. J. Exp. Med. (2005) 201:1061-1067.
95. +. Immunol. (2004) 172:5149-5153.